(VAPX) Vanguard FTSE Developed - Ratings and Ratios
Australia, Hong Kong, South Korea, Singapore
Description: VAPX Vanguard FTSE Developed
The Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF USD Distributing EUR is an exchange-traded fund (ETF) that tracks the performance of the FTSE Developed Asia Pacific ex Japan Index. As an Asia-Pacific ex-Japan Equity ETF, it provides investors with diversified exposure to the regions equity markets, excluding Japan.
Key Performance Indicators (KPIs) for this ETF include its Assets Under Management (AUM), currently standing at approximately €1.083 billion. The funds liquidity is relatively moderate, with an average trading volume of around 2,350 units. Its price movements are characterized by a relatively low Average True Range (ATR) of 0.75%, indicating moderate daily price volatility.
Economic drivers influencing this ETFs performance include the overall health of the Asia-Pacific ex-Japan economies, trade dynamics, and regional monetary policies. The funds underlying index comprises stocks from countries such as Australia, China, Hong Kong, and South Korea, making it sensitive to macroeconomic trends in these nations. Investors should monitor indicators like GDP growth rates, inflation, and interest rates in these economies to gauge the ETFs potential performance.
From a technical analysis perspective, the ETFs price is currently near its 20-day Simple Moving Average (SMA20), suggesting a potential stabilization or consolidation phase. The SMA50 and SMA200 are also important levels to watch, as they may act as support or resistance. The ETFs beta of 0.000 indicates that its price movements are not correlated with the broader market, which could be due to its specific investment universe or other factors.
VAPX ETF Overview
| Market Cap in USD | 1,262m |
| Category | Asia-Pacific ex-Japan Equity |
| TER | 0.15% |
| IPO / Inception | 2013-05-21 |
VAPX ETF Ratings
| Growth Rating | 36.5% |
| Fundamental | - |
| Dividend Rating | 54.2% |
| Return 12m vs S&P 500 | -5.25% |
| Analyst Rating | - |
VAPX Dividends
| Dividend Yield 12m | 2.80% |
| Yield on Cost 5y | 3.85% |
| Annual Growth 5y | 9.34% |
| Payout Consistency | 92.8% |
| Payout Ratio | % |
VAPX Growth Ratios
| Growth Correlation 3m | 94.6% |
| Growth Correlation 12m | 25.3% |
| Growth Correlation 5y | 41% |
| CAGR 5y | 7.07% |
| CAGR/Max DD 5y | 0.36 |
| Sharpe Ratio 12m | -0.07 |
| Alpha | -4.73 |
| Beta | 0.720 |
| Volatility | 12.78% |
| Current Volume | 13.4k |
| Average Volume 20d | 2.5k |
| Stop Loss | 24 (-3.1%) |
| Signal | -0.90 |
What is the price of VAPX shares?
Over the past week, the price has changed by -0.44%, over one month by +1.03%, over three months by +8.48% and over the past year by +8.75%.
Is Vanguard FTSE Developed a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VAPX is around 27.34 EUR . This means that VAPX is currently undervalued and has a potential upside of +10.38% (Margin of Safety).
Is VAPX a buy, sell or hold?
What are the forecasts/targets for the VAPX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 30.5 | 23.3% |
VAPX Fundamental Data Overview
Market Cap EUR = 1.08b (1.08b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.08b EUR (1.08b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.08b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.08b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.08b)/V(0.0) * Re(8.67%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)